🟢 Femasys is trading 5.2% up in pre-market as major U.S. indices rise more than 0.6%

Femasys is trading 5.2% up at $2.88 as major U.S. indices rise more than 0.6% in pre-market trading.

• No new company-specific catalyst was identified for September 11, 2026.
• The latest official announcement was a September 9 partnership with CapexMD to expand access to FemaSeed fertility solutions.
• Femasys closed at $2.74 on September 10 after several sharp daily swings; the gain appears primarily aligned with improving global risk sentiment rather than a fresh corporate announcement.